bcbs cover glp 1 GLP-1 Drugs Could Raise Employer Health Premiums BCBSM pulling back on GLP-1

Orian Shirihai, Ph.D., Associate Professor at Boston University School of Medicine, and Marc Liesa, Ph.D., a research associate on Shirihais team at Boston University School of Medicine.

At least not yet.

According to a 2026 report from KFF, insurers are generally more likely to cover GLP-1 drugs prescribed for type 2 diabetes than those prescribed for obesity treatment

The proportion of deaths due to hemorrhagic stroke among middle-aged and older people (35 years) in the 1990s was 38% for Asians, 32% for Hispanics, 24% for blacks, and 18% for whites (47, 48)

A major driver of the change in BBB architecture is tumor-secreted vascular endothelial growth factor (VEGF)